Vietnam Investment Review on MSN
Everest Medicines closes licensing deal with Travere for civorebrutinib
SHANGHAI, July 7, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and ...
FDA grants accelerated approval to Vera's Trutakna for IgA nephropathy, first dual BAFF/APRIL inhibitor. Competes with ...
By Siddhi Mahatole and Puyaan Singh July 7 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had approved ...
Everest Medicines (HKEX 1952.HK) announced the closing of its previously announced exclusive licensing and collaboration agreement with Travere Therapeutics, Inc. (NASDAQ: TVTX) for the development ...
Vera Therapeutics has won FDA approval for Trutakna, a BAFF/APRIL inhibitor for IgA nephropathy (IgAN) that will compete with ...
When Vera Therapeutics in-licensed atacicept from Merck KGaA about six years ago, patients with IgA nephropathy (IgAN) had no ...
SNP and Palantir announced a strategic partnership at Transformation World 2026 to accelerate secure SAP transformations, alongside new Kyano agentic AI tools for data migration and unstructured data ...
Golden Heaven Group Holdings, a Nasdaq-listed amusement park rental operator in China, announced unaudited financial results for the six months ended 31 March 2026, its fiscal first half.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results